Immune Design Corp.
COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF

Abstract:

This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.